In May 2021, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) hosted a second joint roundtable on the challenges of antimicrobial resistance (AMR) in super-aging Japan. The roundtable brought together Japanese and global experts in aging and infectious disease, examining in particular the coupled crises of antimicrobial resistance (AMR) and…

In May 2021, GCOA and the Health and Global Policy Institute (HGPI) hosted a private roundtable of Japanese and global experts and decision makers to examine the connection between innovation for healthy aging and economic growth in super-aging Japan and other rapidly aging societies across the OECD. The roundtable and subsequent report, released in October…

This report summarizes key takeaways from our October 2020 virtual roundtable on health innovation and economic growth in Japan. The report highlights the importance of health innovation in Japan and in ageing societies around the world. GCOA and the Health and Global Policy Institute (HGPI) co-organized the roundtable, which was sponsored by Pfizer Japan. The roundtable was…

This report summarizes the key takeaways from an October 2020 virtual roundtable on antimicrobial resistance (AMR) and explores the multifaceted risks posed by AMR in aging societies globally, and Japan in particular. The roundtable was co-organized by GCOA and the Health and Global Policy Institute (HGPI) and sponsored by Pfizer Japan. Click here to read the full press…

GCOA and Pfizer Global Medical Grants launched a $1 million grant program to improve uptake of vaccines among Japanese older adults. The Vaccines for All: Longevity Unleashed for Everyone (VALUE) initiative will support, advance, and validate quality improvement strategies that measurably increase the number of older adults in Japan who are immunized against at least one targeted vaccine-preventable…